TABLE 1.
Total (N = 6074) | France (N = 2618) | Asia (N = 1727) | Latin America (N = 883) | Algeria (N = 755) | Middle East (N = 91) | |
---|---|---|---|---|---|---|
Age, years | ||||||
Median | 70 | 72 | 70 | 68 | 72 | 65 |
<65, % | 27.4 | 26.0 | 26.2 | 37.0 | 20.5 | 49.4 |
65–74, % | 39.3 | 37.6 | 41.6 | 37.6 | 42.1 | 38.5 |
≥75, % | 33.3 | 36.4 | 32.2 | 25.4 | 37.4 | 12.1 |
Type of AUR, % | ||||||
Spontaneous | 70.6 | 71.6 | 68.8 | 56.2 | 88.1 | 71.4 |
Precipitated | 29.4 | 28.4 | 31.2 | 43.8 | 11.9 | 28.6 |
BPH revealed by AUR, % | ||||||
Yes | 36.2 | 33.2 | 37.6 | 39.5 | 40.1 | 30.8 |
No | 63.8 | 66.8 | 62.4 | 60.5 | 59.9 | 69.2 |
Severity of LUTS*, % | ||||||
Mild | 13.3 | 16.8 | 7.6 | 14.8 | 13.6 | 14.3 |
Moderate | 57.5 | 61.3 | 51.8 | 57.2 | 56.9 | 75.0 |
Severe | 29.2 | 21.9 | 40.6 | 27.9 | 29.6 | 10.7 |
DRE estimated prostate size†, g | ||||||
<30, % | 6.5 | 6.1 | 11.3 | 3.7 | 0.3 | 3.3 |
30–50, % | 50.4 | 44.6 | 60.3 | 50.2 | 43.3 | 36.3 |
>50, % | 43.1 | 49.3 | 28.4 | 46.1 | 56.4 | 60.4 |
History of previous AUR | ||||||
Yes, % | 16.5 | 10.2 | 23.6 | 19.6 | 18.0 | 24.2 |
Median delay, months | 6.9 | 7.2 | 7.5 | 7.9 | 4.5 | 8.4 |
Available in 3874 men. Lower urinary tract symptom severity evaluated according to International Prostate Symptom Score.
Available in 5013 men. AUR, acute urinary retention; BPH, benign prostatic hyperplasia; DRE, digital rectal examination; LUTS, lower urinary tract symptoms.